Free Trial

Thermo Fisher Scientific (TMO) Stock Price, News & Analysis

Thermo Fisher Scientific logo
$405.83 -2.45 (-0.60%)
As of 06/30/2025 03:58 PM Eastern

About Thermo Fisher Scientific Stock (NYSE:TMO)

Key Stats

Today's Range
$401.45
$413.28
50-Day Range
$390.17
$434.17
52-Week Range
$385.46
$627.88
Volume
3.92 million shs
Average Volume
1.95 million shs
Market Capitalization
$153.20 billion
P/E Ratio
23.80
Dividend Yield
0.42%
Price Target
$604.05
Consensus Rating
Moderate Buy

Company Overview

Thermo Fisher Scientific Inc. (NYSE:TMO) is a leading provider of scientific instrumentation, reagents and consumables, and software and services to the global life sciences, biotechnology, pharmaceutical, clinical, academic, government, and industrial markets. The company’s portfolio encompasses analytical instruments such as mass spectrometers and chromatography systems, specialty diagnostics including immunoassays and molecular diagnostics, laboratory products ranging from pipettes to freezers, and comprehensive biopharma services covering development, manufacturing and clinical trial support.

Founded in 2006 through the merger of Thermo Electron Corporation and Fisher Scientific International, Thermo Fisher Scientific has grown organically and through strategic acquisitions to broaden its technology offerings and expand its global footprint. The company has integrated technologies such as genetic sequencing, cell and gene therapy support, and digital laboratory management to address evolving customer needs. Its focus on innovation is underscored by an extensive R&D network and collaborations with academic institutions and industry partners.

Thermo Fisher Scientific operates in more than 50 countries, with major research and manufacturing facilities across North America, Europe, Asia Pacific and Latin America. Its customer base spans large pharmaceutical companies, biotechnology firms, hospitals, universities, and government agencies, as well as industrial users in food safety, environmental testing and applied markets. The company leverages regional technical support teams, field service engineers and digital platforms to deliver customized solutions and ensure compliance with local regulations.

Under the leadership of President and Chief Executive Officer Marc N. Casper, Thermo Fisher Scientific emphasizes a culture of continuous improvement, sustainability and operational excellence. The executive team prioritizes investments in automation, digitalization, and green technologies to drive productivity and reduce environmental impact. Through its commitment to advancing science and supporting customers worldwide, the company aims to enable breakthroughs in research, diagnostics and biopharmaceutical production.

AI Generated. May Contain Errors.

Thermo Fisher Scientific Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
100th Percentile Overall Score

TMO MarketRank™: 

Thermo Fisher Scientific scored higher than 100% of companies evaluated by MarketBeat, and ranked 5th out of 943 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Thermo Fisher Scientific has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 16 buy ratings, 4 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Thermo Fisher Scientific has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Thermo Fisher Scientific's stock forecast and price target.
  • Earnings Growth

    Earnings for Thermo Fisher Scientific are expected to grow by 9.79% in the coming year, from $23.28 to $25.56 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Thermo Fisher Scientific is 23.80, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 24.77.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Thermo Fisher Scientific is 23.80, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.44.

  • Price to Earnings Growth Ratio

    Thermo Fisher Scientific has a PEG Ratio of 2.17. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Thermo Fisher Scientific has a P/B Ratio of 3.13. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Thermo Fisher Scientific's valuation and earnings.
  • Percentage of Shares Shorted

    1.30% of the float of Thermo Fisher Scientific has been sold short.
  • Short Interest Ratio / Days to Cover

    Thermo Fisher Scientific has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Thermo Fisher Scientific has recently increased by 3.59%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Thermo Fisher Scientific has a dividend yield of 0.42%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Thermo Fisher Scientific has been increasing its dividend for 8 years.

  • Dividend Coverage

    The dividend payout ratio of Thermo Fisher Scientific is 10.09%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Thermo Fisher Scientific will have a dividend payout ratio of 6.73% next year. This indicates that Thermo Fisher Scientific will be able to sustain or increase its dividend.

  • Read more about Thermo Fisher Scientific's dividend.
  • Percentage of Shares Shorted

    1.30% of the float of Thermo Fisher Scientific has been sold short.
  • Short Interest Ratio / Days to Cover

    Thermo Fisher Scientific has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Thermo Fisher Scientific has recently increased by 3.59%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Thermo Fisher Scientific has a news sentiment score of 1.03. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.90 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 74 news articles for Thermo Fisher Scientific this week, compared to 35 articles on an average week.
  • Search Interest

    38 people have searched for TMO on MarketBeat in the last 30 days. This is an increase of 27% compared to the previous 30 days.
  • MarketBeat Follows

    Only 10 people have added Thermo Fisher Scientific to their MarketBeat watchlist in the last 30 days. This is a decrease of -17% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Thermo Fisher Scientific insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $128,979.00 in company stock.

  • Percentage Held by Insiders

    Only 0.33% of the stock of Thermo Fisher Scientific is held by insiders.

  • Percentage Held by Institutions

    89.23% of the stock of Thermo Fisher Scientific is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Thermo Fisher Scientific's insider trading history.
Receive TMO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Thermo Fisher Scientific and its competitors with MarketBeat's FREE daily newsletter.

TMO Stock News Headlines

"I'm risking my reputation on this"
Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.
TMO - Thermo Fisher Scientific Inc News - Morningstar
Leerink Partnrs Issues Pessimistic Outlook for TMO Earnings
See More Headlines

TMO Stock Analysis - Frequently Asked Questions

Thermo Fisher Scientific's stock was trading at $520.23 at the beginning of 2025. Since then, TMO shares have decreased by 22.0% and is now trading at $405.83.
View the best growth stocks for 2025 here
.

Thermo Fisher Scientific Inc. (NYSE:TMO) released its quarterly earnings results on Wednesday, April, 23rd. The medical research company reported $5.15 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $5.10 by $0.05. Thermo Fisher Scientific's quarterly revenue was up .2% compared to the same quarter last year.
Read the conference call transcript
.

Thermo Fisher Scientific's board authorized a stock repurchase plan on Friday, November 15th 2024, which permits the company to repurchase $4,000,000,000 in shares, according to EventVestor. This means that the company could reacquire up to 2% of its shares through open market purchases. Shares buyback plans are generally an indication that the company's board believes its shares are undervalued.

Thermo Fisher Scientific subsidiaries include these companies: Henogen, Phinotex, Qiagen, Brammer Bio, HighChem, Gatan Inc, IntegenX, and more.

Shares of TMO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Thermo Fisher Scientific investors own include BlackRock (BLK), Broadcom (AVGO), UnitedHealth Group (UNH), ServiceNow (NOW), The Goldman Sachs Group (GS), Illinois Tool Works (ITW) and NVIDIA (NVDA).

Company Calendar

Record date for 4/15 Dividend
3/14/2025
Ex-Dividend for 4/15 Dividend
3/14/2025
Dividend Payable
4/15/2025
Last Earnings
4/23/2025
Record date for 7/15 Dividend
6/13/2025
Ex-Dividend for 7/15 Dividend
6/13/2025
Today
7/01/2025
Dividend Payable
7/15/2025
Next Earnings (Estimated)
7/23/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Life Sciences Tools & Services
Current Symbol
NYSE:TMO
Employees
125,000
Year Founded
1956

Price Target and Rating

Average Stock Price Target
$604.05
High Stock Price Target
$686.00
Low Stock Price Target
$450.00
Potential Upside/Downside
+48.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
20 Analysts

Profitability

Trailing P/E Ratio
23.80
Forward P/E Ratio
17.43
P/E Growth
2.17
Net Income
$6.34 billion
Pretax Margin
16.48%

Debt

Sales & Book Value

Annual Sales
$42.88 billion
Cash Flow
$29.86 per share
Price / Cash Flow
13.59
Book Value
$129.54 per share
Price / Book
3.13

Miscellaneous

Free Float
376,248,000
Market Cap
$153.20 billion
Optionable
Optionable
Beta
0.78

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NYSE:TMO) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners